StonvexLoading…
StonvexStonvexStonvexCore line items from SUZ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | BRL 50.12B | BRL 47.40B | BRL 39.76B | BRL 49.83B |
Operating Income | BRL 10.65B | BRL 15.69B | BRL 12.22B | BRL 22.22B |
Net Income | BRL 13.44B | BRL -7.04B | BRL 14.11B | BRL 23.39B |
EPS (Diluted) | BRL 10.82 | BRL -5.59 | BRL 10.85 | BRL 17.57 |
Total Assets | BRL 167.94B | BRL 165.94B | BRL 143.59B | BRL 133.20B |
Total Liabilities | BRL 123.98B | BRL 133.52B | BRL 98.78B | BRL 100.03B |
Cash & Equivalents | BRL 15.18B | BRL 9.02B | BRL 8.35B | BRL 9.51B |
Free Cash Flow OCF − CapEx | BRL 13.57B | BRL 11.41B | BRL 5.64B | BRL 11.85B |
Shares Outstanding | Not available | Not available | 1324.12B | 1361.26B |